April 6, 2021
UNC-Chapel Hill scientists discovered microRNA-29 is an important cellular switch controlling late-stage brain development, a foundational discovery that will help researchers explore new therapeutic approaches for neurodevelopmental conditions.
March 31, 2021
Participating households in Greenville, Pitt County, NC will receive free month-long supplies of rapid tests aimed at reducing community transmission of COVID-19. UNC School of Medicine’s Giselle Corbie-Smith, MD, and Duke colleagues will conduct research to test effectiveness of the program.
March 29, 2021
Research from the UNC School of Medicine lab of Jenny Ting, PhD, shows that the widely used drug metformin reduces metabolism of infected T cells to suppress HIV replication.
March 24, 2021
A pilot study from researchers at NC State and UNC school of Medicine shows evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder. Flavio Frohlich, PhD, is the UNC School of Medicine lead.
March 18, 2021
Researchers in the UNC School of Medicine Lab of Thomas Kash, PhD, published new findings in the journal Neuron showing how neurons in two brain regions use dopamine to promote pain responses differently in male and female mice.
March 11, 2021
A study led by Muneera Kapadia, MD, associate professor of surgery in the UNC School of Medicine, is the first to examine the effect of a surgeon’s mask on communication with patients in the clinic setting. Results suggest that not seeing the surgeon’s face may have negative consequences on the surgeon-patient relationship.
March 8, 2021
The findings reported on a secondary objective to reduce time to negative test result of infectious SARS-CoV-2 virus in individuals with symptomatic COVID-19. UNC School of Medicine’s William Fischer, MD, is the lead investigator on the study of Molnupiravir, the investigational drug also known as EIDD-2801.
March 4, 2021
The discovery, from the UNC School of Medicine lab of Mark Zylka, PhD, offers pain researchers a new, precise target to treat inflammation associated with neuropathic pain.
March 3, 2021
First-year college students are reporting symptoms of depression and anxiety significantly more often than they were before the coronavirus pandemic, according to a study co-authored by Krista Perreira, PhD, professor in the UNC Department of Social Medicine.
March 2, 2021
UNC-Chapel Hill scientists Charles Carter, Qi Zhang, and Abigail Knight were awarded $1 million from the W.M. Keck Foundation to answer the age-old question: How did life on Earth begin?
March 2, 2021
UNC-Chapel Hill research, led by Allison Aiello, PhD, and Emily Ciccone, MD, shows that individuals previously infected with SARS-CoV-2 develop a significant antibody response to the first dose of mRNA-based COVID-19 vaccines.
February 23, 2021
Led by Klara Klein, MD, PhD, the study showed that treatment with 800mg of TTP399 demonstrated statistically significant reductions in HbA1c and clinically relevant reduction in the frequency of severe or symptomatic hypoglycemia.